Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Medicine and Health Sciences
The Comparison Of Folate And Vitamin B12 Levels Between Depressive And Nondepressive Postmenopausal Women, Özlem Şengül, Di̇lek Uygur, Mustafa Güleç, Berna Di̇lbaz, Esma Meltem Şi̇mşek, Ümi̇t Göktolga
The Comparison Of Folate And Vitamin B12 Levels Between Depressive And Nondepressive Postmenopausal Women, Özlem Şengül, Di̇lek Uygur, Mustafa Güleç, Berna Di̇lbaz, Esma Meltem Şi̇mşek, Ümi̇t Göktolga
Turkish Journal of Medical Sciences
To investigate if there is any association between the serum folate and vitamin B12 status and the depressive symptoms in postmenopausal women. Materials and methods: The study included 95 postmenopausal women. The Center for Epidemiologic Studies Depression Scale (CES-D) was used to assess their depressive symptoms. The investigated women were classified into 2 groups based on the existence of depressive symptoms. These 2 groups were compared in terms of folic acid and vitamin B12 levels. Results: Among 95 cases, 27 postmenopausal women scored 16 or more on the CES-D scale and were classified as the depressive group (Group 1), and …
Effects Of Oral Hormone Replacement Therapy On Mean Platelet Volume In Postmenopausal Women, İkbal Kaygusuz, Serap Aynur Si̇mavli, Ayla Eser, İlknur İnegöl Gümüş, Selcen Yüksel, Zehra Candan İltemi̇r Duvan, Hasan Kafali
Effects Of Oral Hormone Replacement Therapy On Mean Platelet Volume In Postmenopausal Women, İkbal Kaygusuz, Serap Aynur Si̇mavli, Ayla Eser, İlknur İnegöl Gümüş, Selcen Yüksel, Zehra Candan İltemi̇r Duvan, Hasan Kafali
Turkish Journal of Medical Sciences
To examine the effects of hormone replacement therapy (HRT) on mean platelet volume (MPV), lipid profile, and C-reactive protein (CRP) levels in postmenopausal women who have a high risk and incidence of cardiovascular disease. Materials and methods: This study was performed retrospectively. Twenty-seven healthy postmenopausal women received 1 mg estradiol and 2 mg drospirenone orally for 6 months. Twenty-eight healthy postmenopausal women not taking any HRT were admitted to the study as the control population. Results: Time effect (independent from group effect) was statistically significant for the MPV variable (P = 0.025), but there was no significant change in MPV …
Hormone Replacement Therapy-Related Changes In The Early Postmenopausal Period (Critical Window): An In Vivo Brain Proton Magnetic Resonance Spectroscopy Study, Kamran Mahmutyazicioğlu, Fahri̇ Hali̇t Beşi̇r, Mustafa Bardakçi, Hami̇t Alper Tanriverdi̇, Handan Ankarali
Hormone Replacement Therapy-Related Changes In The Early Postmenopausal Period (Critical Window): An In Vivo Brain Proton Magnetic Resonance Spectroscopy Study, Kamran Mahmutyazicioğlu, Fahri̇ Hali̇t Beşi̇r, Mustafa Bardakçi, Hami̇t Alper Tanriverdi̇, Handan Ankarali
Turkish Journal of Medical Sciences
Findings from clinical studies in postmenopausal women with late initiation of hormone replacement therapy (HRT) that test whether HRT protects cognitive functions in women are inconsistent. The aim of this study was to investigate the effects of HRT on brain metabolite ratios when initiated in the early postmenopausal period (critical window). Materials and methods: Proton magnetic resonance spectrometry (1H MRS) was performed in 4 brain regions of 47 healthy postmenopausal women (21 received HRT, 26 did not). The subjects were aged between 45 and 65 years. The duration of HRT ranged from 1 to 12 years (mean: 6.3 years). The …